Clinical Trial

ENVIEANCILLAIRE: Efficacy of Nirsevimab in Children Hospitalised With RSV Bronchiolitis - A Subsidiary Study on the Immune Signature and Microbial Environment

Study acronym: ENVIEANCILLAIR
Recruiting
View on ClinicalTrials.gov →
Summary
Among children aged ≤ 6 months included in the ENVIE study, the ENVIE\_ancillaire study will be offered to cases of RSV infection or to controls. The study involves a nasopharyngeal swab using a FLOQ-SWAB™ swab and a fingertip sample (dextro type). These samples will be collected specifically for the purpose of studying immunity. A blood sample may also be requested for children weighing ≥5 kg who are included in the ENVIE\_ancillaire study. The purpose of this sample collection will be to conduct an advanced immunological study
Trial Details
NCT Number NCT07698769
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions Mucosal Cytokine Profile of Patients (Type I and III Interferons, Pro-inflammatory Cytokines)
Enrollment 110 participants
Start Date 2024-12-05
Primary Completion 2026-12-05 (estimated)
Study Completion 2026-12-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-13